In our on going question and answer series, Basser Center genetic counselors and Basser Executive Director Susan, MD, address specific topics about BRCA and hereditary cancer.

Back to all videos

Ask Dr. Domchek: Ovarian Cancer Surveillance & More

Basser Center Executive Director Susan Domchek, MD, answers a series of frequently asked questions. She discusses ovarian cancer surveillance, BRCA mutations in the Ashkenazi Jewish community, COVID vaccines, and more.

Research Innovations in BRCA-Related Prostate Cancer

Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses BRCA-related prostate cancer treatment, recent scientific innovations, and the importance of philanthropy.

Ask Dr. Domchek: Upcoming Advances in Genetics

Basser Center Executive Director Susan Domchek, MD, discusses what she hopes will be the next advances in BRCA-related research and hereditary cancer care, including liquid biopsies and determining individualized risk.

Ask a Genetic Counselor: BRCA & Men

Basser Center Genetic Counselor Jacquelyn Powers, MS, LCGC, discusses the basic of BRCA mutations in men and shares helpful information like associated cancer risk and typical screening recommendations.

Ask Dr. Domchek: Determining Individualized Risk for Hereditary Cancer

Basser Executive Director Susan, Domchek, MD, discusses BRCA mutations and the ways in which individualized risk for hereditary cancer can be determined.

Ask a Genetic Counselor: When to Consider Genetic Retesting

Basser Center genetic counselor Dana Farengo Clark, MS, LCGC, discusses when to consider getting additional genetic testing and why to consider scheduling an appointment with a genetic counselor after you've already been tested.

Ask a Genetic Counselor: Genetic Testing and Variants of Uncertain Significance

Basser Center genetic counselor Jessica Ebrahimzadeh, MS, LCGC, discusses genetic testing and what it means to receive a variant of uncertain significance in your results.

Ask Dr. Domchek: Enhancing PARP Inhibitors

Basser Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

Ask Dr. Domchek: Different Types of Breast Cancers

Basser Executive Director Susan Domchek, MD, discusses different types of hereditary breast cancer.

Ask Dr. Domchek: Alcohol and Cancer Risk

Basser Executive Director Susan Domchek, MD, discusses alcohol and how it relates to cancer risk.

Ask Dr. Domchek: Lifestyle Interventions to Reduce Cancer Risk

Basser Executive Director Susan Domchek, MD, discusses lifestyle interventions, such as diet and exercise, to reduce hereditary cancer risk.

Ask Dr. Domchek: BRCA and Individualized Risk

Basser Executive Director Susan Domchek, MD, discusses hereditary cancer risk for BRCA mutation carriers and ways in which that might impact individuals differently.